Deninta SC Injection
By Deninta
Rx
1ml Injection in a Prefilled syringe

Composition
Denosumab(60mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
August, 2025

liver
When using Deninta SC Injection, it is important to be cautious if you have severe liver disease. Patients with liver issues may require a dose adjustment for this injection, so consulting your doctor is essential. If you have liver impairment or any concerns about your liver health, it is recommended to seek advice from your healthcare provider before using Deninta SC Injection.

kidney
Deninta SC Injection requires caution in severe kidney disease. Adjustments in dosage may be necessary. Consult your doctor if you have kidney issues or concerns about using Deninta SC Injection.

alcohol
Caution is recommended when drinking alcohol while using Deninta SC Injection. It is advisable to consult your doctor regarding any potential interactions.

driving
Deninta SC Injection typically does not impact your driving ability. It is advised to drive or handle machinery only when fully alert after taking Deninta SC Injection.

pregnancy
Deninta SC Injection is not safe to use during pregnancy, as it can harm the developing baby. If you are a woman who can bear children, ensure to use effective birth control during treatment and for 5 months after stopping Deninta SC Injection. Notify your doctor if you are pregnant or planning pregnancy.

breastfeeding
Deninta SC Injection is likely unsafe to use during breastfeeding as it may pass into the breastmilk and harm the baby, based on limited human data. Consult your doctor to determine if it is safe for breastfeeding mothers to use Deninta SC Injection.
Habit Forming | No |
Chemical Class | Monoclonal Antibody |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹20000
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024